Valbenazine for obsessive compulsive disorder
Treatments studied
Part of Mental health clinical trials.
This study tests if valbenazine, a medication that affects brain chemicals, can reduce OCD symptoms in adults. Participants must have moderate to severe OCD and take the pill daily for the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with obsessive compulsive disorder (OCD).
- Your OCD symptoms are moderate to severe (score of at least 21 on a standard OCD scale).
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You have no unstable medical conditions, liver problems, or recent changes in psychiatric medication.
- You have no history of psychosis or bipolar disorder, and you are not at immediate risk of suicide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
This trial is testing a brain implant that sends electrical signals to specific areas of the brain to help people with very severe obsessive-compulsive disorder (OCD) that has not improved with other treatments. The goal is to see if this treatment can reduce OCD symptoms and improve daily functioning.
This trial tests a non-invasive brain stimulation technique called tDCS (which uses a mild electrical current on the scalp) to see if it can reduce OCD symptoms. It is for people whose OCD has not improved with standard treatments.
This trial tests whether a gentle brain stimulation (tDCS) combined with facing your fears can help people with hard-to-treat OCD. If you've tried multiple treatments without relief, this study may offer a new option.
This study tests a personalized brain-stimulation approach to help people with obsessive-compulsive disorder (OCD) focused on contamination worries. If you have the “contamination” type of OCD and meet the safety and medication rules, you may be able to join and see whether this targeted treatment reduces symptoms.
This study looks at whether deep brain stimulation (DBS) helps people with long-term, treatment-resistant obsessive-compulsive disorder (OCD), and how it affects quality of life. It involves careful screening because it’s meant for OCD that has not responded to several medication and therapy attempts.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.